Regulatory T cells (T~reg~), defined by the expression of the transcription factor Foxp3, are crucial for immunological self-tolerance and homeostasis.[@R1] T~reg~ cells are mainly developed in the thymus as natural T~reg~ cells (nT~reg~), which can be best depicted by a 2-step model. The initial signals from the high-affinity T-cell receptor (TCR) and CD28 co-stimulation lead to the generation of a precursor population with enhanced cytokine responsiveness, which then responds to signals from γc-dependent cytokines, especially IL-2 for full induction of Foxp3 expression[@R2].

Consistent with the importance of TCR and co-stimulatory signals for nT~reg~ development, several transcription factors downstream of TCR/CD28 have been implicated in Foxp3 expression[@R2]. For instance, among TCR-activated NFκB members, c-Rel has a crucial role in Foxp3 induction by binding to an intronic conserved noncoding sequence (CNS) in the *Foxp3* locus, known as *Foxp3-*CNS3.[@R2] Concurrent with transcriptional activation of Foxp3 expression, TCR stimulation also leads to epigenetic modification by establishing a T~reg~-specific CpG hypomethylation pattern in *Foxp3*-CNS2, as well as in other T~reg~ signature genes.[@R3] Both transcriptional activation of Foxp3 expression and establishment of T~reg~-specific epigenetic modifications are required for a full developmental and suppressive program of nT~reg~ cells. Aside from TCR/CD28 stimulation, IL-2 directly contributes to Foxp3 transcription by activating Stat5, and thus is intimately linked to nT~reg~ development.[@R2] IL-2 is also required for functional programming and expansion of nT~reg~ cells during thymic development.[@R4] While remarkable advances have been made in deciphering TCR- and IL-2-induced intrinsic events in nT~reg~ development, how the production of extrinsic signals such as IL-2 is controlled remains poorly understood.

We addressed this issue by focusing on growth factor independent 1 (Gfi1), a transcription repressor important for immune and hematopoietic cell development and function. Since Gfi1 has been implicated in early thymocyte development,[@R5] we utilized a mouse genetic model with T cell-specific deletion of Gfi1 via CD4-Cre (*Gfi1*^CD4-Cre^) to circumvent the early developmental defects associated with germ-line deletion of Gfi1. We identified a previously unappreciated mechanism in which Gfi1 exerts a non-cell-autonomous effect to curtail nT~reg~ development by inhibiting IL-2 production from conventional T cells[@R6] ([Fig. 1](#F1){ref-type="fig"}). Combining pharmacological blockade of IL-2 signaling and genetic deletion of *Il2*, we showed that excessive IL-2 production in *Gfi1*^CD4-Cre^ mice underlined the augmented nT~reg~ development in *Gfi1*^CD4-Cre^ mice. Furthermore, when wild-type bystander cells were introduced into a *Gfi1*^CD4-Cre^-predominant environment created by bone marrow chimeras, they exhibited an increased proportion of Foxp3^+^ nT~reg~ cells, indicative of an nT~reg~-inducing environment established by Gfi1-deficient thymocytes. This non-cell-autonomous effect of Gfi1 on nT~reg~ development was further supported by the lack of effect on nT~reg~ development when Gfi1 was deleted selectively in T~reg~ cells. Importantly, the increased generation of nT~reg~ cells in the absence of Gfi1 was independent of its pro-survival effect. Taken together, Gfi1-mediated transcriptional control of extrinsic signals (IL-2) orchestrates an unconventional mechanism for nT~reg~ development, thereby complementing the well-recognized T~reg~-intrinsic transcriptional pathways.

![**Figure 1.** Control of Foxp3^+^ nT~reg~ cells and antitumor immunity by Gfi1. Loss of Gfi1 in conventional T cells (T~conv~) leads to increased secretion of IL-2, which promotes nT~reg~ cell expansion in the thymus and periphery. Gfi1 deletion also upregulates T~reg~ effector molecules CD103 and CD73. Collectively, Gfi1 deficiency in T cells dampens antitumor immunity. ↑, increased expression or cellularity.](cc-12-3581-g1){#F1}

Deficiency of Gfi1 not only led to increased generation of nT~reg~ cells, but also potentiated their suppressive activity.[@R6] Because tumor-infiltrating T~reg~ cells have a crucial role in dampening antitumor immunity, we examined whether the increased T~reg~ cellularity and function in the absence of Gfi1 impaired antitumor immunity. When challenged with B16 melanoma cells, *Gfi1*^CD4-cre^ mice were unable to control late-stage tumor growth, associated with significantly elevated T~reg~/non-T~reg~ ratios. Moreover, Gfi1-deficient nT~reg~ cells showed increased expression of T~reg~ effector molecules CD103 and CD73 under steady-state and in the tumor environment. The integrin molecule CD103 marks the subset of T~reg~ cells with elevated suppressive activity in various contexts, including antitumor responses, whereas the ectonucleotidase CD73 is important for converting the proinflammatory extracellular ATP to immunosuppressive adenosine. Therefore, Gfi1 deficiency in T cells established a tumor-supportive environment by both increasing T~reg~ cellularity in tumors and endowing them with a greater suppressive activity via upregulating CD103 and CD73 expression. Mechanistically, direct inhibition of CD103 and CD73 by Gfi1 has been reported in induced T~reg~ cells[@R7] and T~H~17 cells,[@R8] respectively. Our results support and extend these findings by showing that Gfi1-deficient nT~reg~ cells express elevated levels of CD103 and CD73.[@R6] It is also noteworthy that the effect of Gfi1 deficiency on CD103 upregulation appeared to be less pronounced in the absence of IL-2 (our unpublished findings), suggesting that enhanced IL-2 production in the unmanipulated *Gfi1*^CD4-cre^ thymus also contributes to CD103 upregulation. This interpretation is consistent with the effect of IL-2 to upregulate CD103 and CD73 expression for functional maturation of thymic nT~reg~ cells.[@R4] We therefore propose that Gfi1 deficiency upregulates CD103 and CD73 expression in nT~reg~ cells via both direct and indirect mechanisms, thereby potentiating nT~reg~-mediated immunosuppression in *Gfi1*^CD4-Cre^ mice.

In conclusion, Gfi1 orchestrates an important cell-extrinsic control mechanism for nT~reg~ development by regulating IL-2 production from conventional T cells. Further, Gfi1 likely exerts both extrinsic and intrinsic effects on nT~reg~-suppressive activity by mitigating IL-2 production from conventional T cells and by directly regulating nT~reg~ effector molecules, respectively. Given the extensive effects of Gfi1 deficiency on nT~reg~ development and function, strategies to enhance Gfi1 expression and/or activity represent a possible approach for antitumor immunotherapy.
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